2.5384
Edesa Biotech Inc stock is traded at $2.5384, with a volume of 23,523.
It is up +1.94% in the last 24 hours and up +5.77% over the past month.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
See More
Previous Close:
$2.49
Open:
$2.47
24h Volume:
23,523
Relative Volume:
0.43
Market Cap:
$17.86M
Revenue:
-
Net Income/Loss:
$-7.72M
P/E Ratio:
-0.9617
EPS:
-2.6394
Net Cash Flow:
$-6.25M
1W Performance:
-11.86%
1M Performance:
+5.77%
6M Performance:
+12.63%
1Y Performance:
-37.29%
Edesa Biotech Inc Stock (EDSA) Company Profile
Name
Edesa Biotech Inc
Sector
Industry
Phone
(905) 475-1234
Address
100 SPY COURT, MARKHAM, ON
Compare EDSA with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
EDSA
Edesa Biotech Inc
|
2.5384 | 18.28M | 0 | -7.72M | -6.25M | -2.6394 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Edesa Biotech Inc Stock (EDSA) Latest News
Is Edesa Biotech Inc. still worth holding after the dipQuarterly Market Review & Community Supported Trade Ideas - newser.com
Has Edesa Biotech Inc. found a price floorDay Trade & Low Risk Investment Opportunities - newser.com
Why Edesa Biotech Inc. is moving todayWeekly Investment Recap & Verified Stock Trade Ideas - newser.com
Published on: 2025-10-10 09:34:26 - newser.com
Will Edesa Biotech Inc. stock maintain growth storyQuarterly Portfolio Review & Fast Exit and Entry Trade Guides - newser.com
Is Edesa Biotech Inc. stock resilient to inflationEarnings Growth Report & Expert Verified Movement Alerts - newser.com
What candlestick patterns are forming on Edesa Biotech Inc.July 2025 Retail & Advanced Technical Signal Analysis - newser.com
Edesa Biotech Inc Stock Analysis and ForecastMomentum Stock Picks & Low Entry Cost Investments - earlytimes.in
How to use a screener to detect Edesa Biotech Inc. breakoutsMarket Activity Report & Reliable Entry Point Trade Alerts - newser.com
Does Edesa Biotech Inc. fit your quant trading modelWeekly Loss Report & High Conviction Trade Alerts - newser.com
Tools to assess Edesa Biotech Inc.’s risk profile2025 Market Trends & Low Risk High Win Rate Stock Picks - newser.com
Published on: 2025-10-05 05:14:32 - newser.com
Sentiment analysis tools applied to Edesa Biotech Inc.July 2025 Review & Fast Gaining Stock Reports - newser.com
Volume spikes in Edesa Biotech Inc. stock – what they mean2025 Top Gainers & Community Verified Swing Trade Signals - newser.com
Future of United States Contact Dermatitis Treatment Market | - openPR.com
Critical Comparison: Sana Biotechnology (NASDAQ:SANA) & Edesa Biotech (NASDAQ:EDSA) - Defense World
What drives Edesa Biotech Inc stock priceMid Cap Growth Trends & Build Wealth Brick by Brick With Us - earlytimes.in
Edesa Biotech Inc Stock (EDSA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):